{"id":"ticarcillin","rwe":[{"pmid":"41806369","year":"2026","title":"Prevalence and Resistance Patterns of Pseudomonas aeruginosa in a Tunisian Intensive Care Unit.","finding":"","journal":"The American journal of tropical medicine and hygiene","studyType":"Clinical Study"},{"pmid":"41769068","year":"2026","title":"Antimicrobial resistance dynamics in Mycobacterium tuberculosis coinfection systems: A spatiotemporal strain analysis.","finding":"","journal":"Biochemistry and biophysics reports","studyType":"Clinical Study"},{"pmid":"41728971","year":"2026","title":"Functional characterization of a novel class A carbapenemase CAE-1 in carbapenem-resistant Pseudomonas aeruginosa clinical isolates.","finding":"","journal":"Antimicrobial agents and chemotherapy","studyType":"Clinical Study"},{"pmid":"41681363","year":"2026","title":"The Apparent pH Stability of Antibiotic Preparations Used for Uterine Infusions in Mares.","finding":"","journal":"Animals : an open access journal from MDPI","studyType":"Clinical Study"},{"pmid":"41670516","year":"2026","title":"A Ten-Year Study of the Epidemiology and Antimicrobial Resistance of Bacterial Pathogens Associated with Otitis in Crete, Greece.","finding":"","journal":"Clinical laboratory","studyType":"Clinical Study"}],"tags":[{"label":"Penicillin-class Antibacterial","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"J01CA13","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Mature","category":"status"},{"label":"Abscess of lung","category":"indication"},{"label":"Aspiration pneumonia","category":"indication"},{"label":"Bacterial infection due to Klebsiella pneumoniae","category":"indication"},{"label":"Bacterial infection due to Serratia","category":"indication"},{"label":"Bacterial pneumonia","category":"indication"},{"label":"Bacterial septicemia","category":"indication"},{"label":"Approved 1970s","category":"decade"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":225.627,"date":"","count":51,"signal":"Bone erosion","source":"DrugCentral FAERS","actionTaken":"Reported 51 times (LLR=226)"},{"llr":218.438,"date":"","count":51,"signal":"Bronchiectasis","source":"DrugCentral FAERS","actionTaken":"Reported 51 times (LLR=218)"},{"llr":172.59,"date":"","count":51,"signal":"Hypothyroidism","source":"DrugCentral FAERS","actionTaken":"Reported 51 times (LLR=173)"}],"drugInteractions":[{"url":"/drug/tobramycin","drug":"tobramycin","action":"Monitor closely","effect":"May interact with Tobramycin","source":"DrugCentral","drugSlug":"tobramycin"}],"commonSideEffects":[],"contraindications":["Infectious mononucleosis","Kidney disease","Pseudomembranous enterocolitis"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TICARCILLIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:32:46.847700+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:32:52.319596+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TICARCILLIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:32:52.984051+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1449/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:32:53.685916+00:00"}},"allNames":["ticarcillin","ticarcillin disodium","ticarcillin sodium"],"offLabel":[],"synonyms":["ticarcillin","ticarcillin disodium","ticarcillin sodium"],"timeline":[{"date":"1976-11-09","type":"positive","source":"DrugCentral","milestone":"FDA approval"},{"date":"1986-12-19","type":"neutral","source":"FDA Orange Book","milestone":"Generic entry — 1 manufacturer approved"}],"aiSummary":"Ticarcillin is a Penicillin-class Antibacterial small molecule originally developed by, currently owned by. It was FDA approved in 1976 for various bacterial infections, including lung abscess, aspiration pneumonia, and urinary tract infections. Ticarcillin is off-patent and has a generic manufacturer. Its half-life is 1.0 hours, but it has 0% bioavailability. It is used to treat a range of bacterial infections caused by various pathogens.","approvals":[{"date":"1976-11-09","orphan":false,"company":"","regulator":"FDA"}],"ecosystem":[{"indication":"Abscess of lung","otherDrugs":[{"name":"benzylpenicillin","slug":"benzylpenicillin","company":"Pfizer"},{"name":"cefoxitin","slug":"cefoxitin","company":""}],"globalPrevalence":null},{"indication":"Aspiration pneumonia","otherDrugs":[{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"},{"name":"benzylpenicillin","slug":"benzylpenicillin","company":"Pfizer"},{"name":"clindamycin","slug":"clindamycin","company":"Pharmacia And Upjohn"},{"name":"clindamycin phosphate","slug":"clindamycin-phosphate","company":"Pharmacia And Upjohn"}],"globalPrevalence":null},{"indication":"Bacterial infection due to Klebsiella pneumoniae","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"}],"globalPrevalence":null},{"indication":"Bacterial infection due to Serratia","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"},{"name":"cefotaxime","slug":"cefotaxime","company":"Sanofi Aventis Us"}],"globalPrevalence":null},{"indication":"Bacterial pneumonia","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Bacterial septicemia","otherDrugs":[{"name":"Polymyxin B","slug":"polymyxin-b","company":"Monarch Pharms"},{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"}],"globalPrevalence":null},{"indication":"Bacterial urinary infection","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"avibactam","slug":"avibactam","company":"Cerexa Inc"}],"globalPrevalence":null},{"indication":"Bacteroides Endometritis","otherDrugs":[{"name":"cefotaxime","slug":"cefotaxime","company":"Sanofi Aventis Us"},{"name":"cefotetan","slug":"cefotetan","company":""},{"name":"cefoxitin","slug":"cefoxitin","company":""},{"name":"clavulanic acid","slug":"clavulanic-acid","company":"Dr Reddys Labs Inc"}],"globalPrevalence":null}],"mechanism":{"novelty":"Follow-on","modality":"Small Molecule","drugClass":"Penicillin-class Antibacterial","explanation":"","oneSentence":"","technicalDetail":"Ticarcillin exerts its antibacterial effect by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall, inhibiting the transpeptidation reaction that cross-links peptidoglycan chains, ultimately leading to cell lysis and death."},"commercial":{"launchDate":"1976","_launchSource":"DrugCentral (FDA 1976-11-09, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2656","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=TICARCILLIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TICARCILLIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:55:59.930429","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:32:55.247992+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ampicillin","drugSlug":"ampicillin","fdaApproval":"1965-12-17","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"carbenicillin","drugSlug":"carbenicillin","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"amoxicillin","drugSlug":"amoxicillin","fdaApproval":"1974-12-09","patentExpiry":"May 7, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"carindacillin","drugSlug":"carindacillin","fdaApproval":"1972-10-26","relationship":"same-class"},{"drugName":"bacampicillin","drugSlug":"bacampicillin","fdaApproval":"1980-12-22","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"azlocillin","drugSlug":"azlocillin","fdaApproval":"1982-09-03","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mezlocillin","drugSlug":"mezlocillin","fdaApproval":"1981-09-21","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mecillinam","drugSlug":"mecillinam","fdaApproval":"","relationship":"same-class"},{"drugName":"piperacillin","drugSlug":"piperacillin","fdaApproval":"1981-12-29","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"hetacillin","drugSlug":"hetacillin","fdaApproval":"","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"ticarcillin","indications":{"approved":[{"name":"Abscess of lung","source":"DrugCentral","snomedId":73452002,"regulator":"FDA"},{"name":"Aspiration pneumonia","source":"DrugCentral","snomedId":422588002,"regulator":"FDA"},{"name":"Bacterial infection due to Klebsiella pneumoniae","source":"DrugCentral","snomedId":186435004,"regulator":"FDA"},{"name":"Bacterial infection due to Serratia","source":"DrugCentral","snomedId":71120004,"regulator":"FDA"},{"name":"Bacterial pneumonia","source":"DrugCentral","snomedId":53084003,"regulator":"FDA"},{"name":"Bacterial septicemia","source":"DrugCentral","snomedId":10001005,"regulator":"FDA"},{"name":"Bacterial urinary infection","source":"DrugCentral","snomedId":312124009,"regulator":"FDA"},{"name":"Bacteroides Endometritis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Bacteroides Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Citrobacter Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Complicated Genitourinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Complicated Urinary Tract Infections","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"E. Coli Endometritis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"E. Coli Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Empyema of pleura","source":"DrugCentral","snomedId":58554001,"regulator":"FDA"},{"name":"Enterobacter Endometritis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Enterobacter Pneumonia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Escherichia coli urinary tract infection","source":"DrugCentral","snomedId":301011002,"regulator":"FDA"},{"name":"Genitourinary Tract Infections","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus influenzae pneumonia","source":"DrugCentral","snomedId":70036007,"regulator":"FDA"},{"name":"Infection due to Enterobacteriaceae","source":"DrugCentral","snomedId":128945009,"regulator":"FDA"},{"name":"Infection due to Escherichia coli","source":"DrugCentral","snomedId":71057007,"regulator":"FDA"},{"name":"Infection due to Staphylococcus aureus","source":"DrugCentral","snomedId":406602003,"regulator":"FDA"},{"name":"Infection of skin AND/OR subcutaneous tissue","source":"DrugCentral","snomedId":19824006,"regulator":"FDA"},{"name":"Infectious disease of abdomen","source":"DrugCentral","snomedId":128070006,"regulator":"FDA"},{"name":"Inflammatory Disease of Female Pelvic Organs","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Klebsiella Endometritis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Klebsiella Pneumoniae Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Klebsiella cystitis","source":"DrugCentral","snomedId":60867007,"regulator":"FDA"},{"name":"Morganella Septicemia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Osteomyelitis due to Staphylococcus aureus","source":"DrugCentral","snomedId":428783003,"regulator":"FDA"},{"name":"Pelvic abscess","source":"DrugCentral","snomedId":111367007,"regulator":"FDA"},{"name":"Pneumonia due to Escherichia coli","source":"DrugCentral","snomedId":51530003,"regulator":"FDA"},{"name":"Pneumonia due to Pseudomonas","source":"DrugCentral","snomedId":41381004,"regulator":"FDA"},{"name":"Proteus pneumonia","source":"DrugCentral","snomedId":195888009,"regulator":"FDA"},{"name":"Proteus septicemia","source":"DrugCentral","snomedId":300986008,"regulator":"FDA"},{"name":"Providencia Septicemia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Pseudomonas Aeruginosa Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Rhinoscleroma","source":"DrugCentral","snomedId":72409005,"regulator":"FDA"},{"name":"Salpingitis","source":"DrugCentral","snomedId":88157006,"regulator":"FDA"},{"name":"Sepsis due to Gram negative bacteria","source":"DrugCentral","snomedId":449082003,"regulator":"FDA"},{"name":"Sepsis due to Pseudomonas","source":"DrugCentral","snomedId":448813005,"regulator":"FDA"},{"name":"Sepsis due to Staphylococcus aureus","source":"DrugCentral","snomedId":448417001,"regulator":"FDA"},{"name":"Septicemia due to Escherichia coli","source":"DrugCentral","snomedId":9323009,"regulator":"FDA"},{"name":"Serratia Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Skin and Skin Structure Morganella Morganii Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Skin and Skin Structure Proteus Infection","source":"DrugCentral","snomedId":"","regulator":"FDA","usPrevalence":null,"globalPrevalence":251400000,"prevalenceMethod":"curated","prevalenceSource":"Pathogens, 2024 (PMID:39452777)"},{"name":"Skin and Skin Structure Providencia Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Skin and Skin Structure Pseudomonas Aeruginosa Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcal pneumonia","source":"DrugCentral","snomedId":22754005,"regulator":"FDA"},{"name":"Staphylococcus Aureus Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcus Aureus Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcus Endometritis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Urinary tract infectious disease","source":"DrugCentral","snomedId":68566005,"regulator":"FDA"}],"offLabel":[{"name":"Abscess of brain","source":"DrugCentral","drugName":"TICARCILLIN"},{"name":"Cholangitis","source":"DrugCentral","drugName":"TICARCILLIN","evidenceCount":3,"evidenceLevel":"emerging"},{"name":"Chronic purulent otitis media","source":"DrugCentral","drugName":"TICARCILLIN"},{"name":"Diabetic Foot Infection","source":"DrugCentral","drugName":"TICARCILLIN","evidenceCount":11,"evidenceLevel":"moderate"},{"name":"Diverticulitis of gastrointestinal tract","source":"DrugCentral","drugName":"TICARCILLIN"},{"name":"Escherichia coli meningitis","source":"DrugCentral","drugName":"TICARCILLIN","evidenceCount":3,"evidenceLevel":"emerging"},{"name":"Infection of bone","source":"DrugCentral","drugName":"TICARCILLIN","evidenceCount":42,"evidenceLevel":"moderate"},{"name":"Infectious disorder of joint","source":"DrugCentral","drugName":"TICARCILLIN"},{"name":"Pseudomonas Aeruginosa Meningitis","source":"DrugCentral","drugName":"TICARCILLIN","evidenceCount":9,"evidenceLevel":"emerging"},{"name":"Pseudomonas Respiratory Tract Infection in Cystic Fibrosis","source":"DrugCentral","drugName":"TICARCILLIN","evidenceCount":16,"evidenceLevel":"moderate"},{"name":"Pyrexia of unknown origin","source":"DrugCentral","drugName":"TICARCILLIN"}],"pipeline":[]},"drugCategory":"mature","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"ampicillin","brandName":"ampicillin","genericName":"ampicillin","approvalYear":"1965","relationship":"same-class"},{"drugId":"carbenicillin","brandName":"carbenicillin","genericName":"carbenicillin","approvalYear":"","relationship":"same-class"},{"drugId":"amoxicillin","brandName":"amoxicillin","genericName":"amoxicillin","approvalYear":"1974","relationship":"same-class"},{"drugId":"carindacillin","brandName":"carindacillin","genericName":"carindacillin","approvalYear":"1972","relationship":"same-class"},{"drugId":"bacampicillin","brandName":"bacampicillin","genericName":"bacampicillin","approvalYear":"1980","relationship":"same-class"},{"drugId":"azlocillin","brandName":"azlocillin","genericName":"azlocillin","approvalYear":"1982","relationship":"same-class"},{"drugId":"mezlocillin","brandName":"mezlocillin","genericName":"mezlocillin","approvalYear":"1981","relationship":"same-class"},{"drugId":"mecillinam","brandName":"mecillinam","genericName":"mecillinam","approvalYear":"","relationship":"same-class"},{"drugId":"piperacillin","brandName":"piperacillin","genericName":"piperacillin","approvalYear":"1981","relationship":"same-class"},{"drugId":"hetacillin","brandName":"hetacillin","genericName":"hetacillin","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT01728363","phase":"PHASE1","title":"Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)","status":"COMPLETED","sponsor":"Phillip Brian Smith","startDate":"2013-01","conditions":["Systemic Infection"],"enrollment":63,"completionDate":"2015-05"},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":["Appendicitis"],"enrollment":1552,"completionDate":"2021-09-01"},{"nctId":"NCT04879030","phase":"PHASE2,PHASE3","title":"Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD","status":"COMPLETED","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2020-01-01","conditions":["COPD Exacerbation Acute"],"enrollment":170,"completionDate":"2020-12-30"},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"},{"nctId":"NCT01667094","phase":"PHASE4","title":"A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis","status":"UNKNOWN","sponsor":"The Alfred","startDate":"2012-09","conditions":["Cystic Fibrosis"],"enrollment":50,"completionDate":"2017-07"},{"nctId":"NCT00092170","phase":"PHASE2","title":"An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-03","conditions":["Infections","Pelvic Infections"],"enrollment":100,"completionDate":"2004-01"},{"nctId":"NCT02158442","phase":"PHASE2","title":"Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients","status":"COMPLETED","sponsor":"Osprey Medical, Inc","startDate":"2013-10","conditions":["Diabetes","Infection"],"enrollment":15,"completionDate":"2015-03"},{"nctId":"NCT01587768","phase":"","title":"WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-11","conditions":["Infections, Bacterial"],"enrollment":1,"completionDate":"2014-07"},{"nctId":"NCT01229046","phase":"PHASE1","title":"Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants","status":"WITHDRAWN","sponsor":"Phillip Brian Smith","startDate":"2010-09","conditions":["Sepsis"],"enrollment":0,"completionDate":""},{"nctId":"NCT00249197","phase":"PHASE3","title":"A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"1997-01","conditions":["Skin Diseases, Bacterial"],"enrollment":413,"completionDate":"1998-07"},{"nctId":"NCT00153634","phase":"NA","title":"Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2004-03","conditions":["Cystic Fibrosis","Chronic Bronchitis"],"enrollment":75,"completionDate":"2007-11"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000148033","MMSL":"5581","NDDF":"002708","UNII":"F93UJX4SWT","VUID":"4019948","CHEBI":"CHEBI:9587","VANDF":"4018409","INN_ID":"3406","RXNORM":"10591","UMLSCUI":"C0040193","chemblId":"CHEMBL1449","ChEMBL_ID":"CHEMBL1449","KEGG_DRUG":"D02241","DRUGBANK_ID":"DB01607","PDB_CHEM_ID":" XT8","PUBCHEM_CID":"36921","SNOMEDCT_US":"111119006","IUPHAR_LIGAND_ID":"10928","SECONDARY_CAS_RN":"29457-07-6","MESH_DESCRIPTOR_UI":"D013982"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.0 hours","clearance":"1.8 mL/min/kg","bioavailability":"0%","fractionUnbound":"0.55%","volumeOfDistribution":"0.16 L/kg"},"publicationCount":2114,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"J01CA13","allCodes":["J01CA13","J01CR03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 10","pmid":"41806369","title":"Prevalence and Resistance Patterns of Pseudomonas aeruginosa in a Tunisian Intensive Care Unit.","journal":"The American journal of tropical medicine and hygiene"},{"date":"2026 Mar","pmid":"41769068","title":"Antimicrobial resistance dynamics in Mycobacterium tuberculosis coinfection systems: A spatiotemporal strain analysis.","journal":"Biochemistry and biophysics reports"},{"date":"2026 Feb 23","pmid":"41728971","title":"Functional characterization of a novel class A carbapenemase CAE-1 in carbapenem-resistant Pseudomonas aeruginosa clinical isolates.","journal":"Antimicrobial agents and chemotherapy"},{"date":"2026 Jan 26","pmid":"41681363","title":"The Apparent pH Stability of Antibiotic Preparations Used for Uterine Infusions in Mares.","journal":"Animals : an open access journal from MDPI"},{"date":"2026 Feb 1","pmid":"41670516","title":"A Ten-Year Study of the Epidemiology and Antimicrobial Resistance of Bacterial Pathogens Associated with Otitis in Crete, Greece.","journal":"Clinical laboratory"}],"companionDiagnostics":[],"genericManufacturers":1,"_genericFilersChecked":true,"genericManufacturerList":["Glaxosmithkline"],"status":"approved","brandName":"TICARCILLIN","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1976","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1976-11-09T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:32:55.247992+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}